Expanding Research Capabilities EMD Millipore has recently launched innovative platforms such as AIDDISON for drug discovery and ChemisTwin for digital reference analysis, indicating a focus on enhancing research productivity and digital solutions, which presents opportunities for selling complementary laboratory software and digital tools.

Strategic Acquisitions The acquisition of Amptec GmbH specializing in mRNA contract manufacturing showcases EMD Millipore’s commitment to expanding its biopharmaceutical manufacturing capabilities, providing potential upsell opportunities for bioprocessing and contract development services.

Investment in Manufacturing Recent significant investments in antibody production facilities in France signal a growth phase in bioproduction, opening avenues for supply chain solutions, equipment sales, and cleanroom or manufacturing technology upgrades.

Industry Collaborations Partnerships with biotech incubators like LabCentral highlight a strategy to foster startup success and innovation, offering opportunities to introduce new lab consumables, instrumentation, and collaboration tools to early-stage biotech firms.

Digital and Data-Driven Focus The adoption of advanced digital platforms and the usage of analytics tools point to a shift towards data-centric laboratory environments, providing opportunities for selling digital infrastructure, automation, and analytics solutions to optimize research workflows.